Discovery of Therapeutic Targets and Potential Drugs to Fight Severe Acute Respiratory Syndrome Coronavirus 2 (SARSCoV-2): A Review
DOI:
https://doi.org/10.37506/ijfmt.v15i2.14731Keywords:
COVID-19, drug discovery, SARS-CoV-2.Abstract
SARS-CoV-2, the causative agent of COVID-19, has led to more than two million deaths worldwide. There
are currently no specific therapies approved to treat COVID-19 and drug repositioning, rather than new
drug discovery, which may be the best short-term option for controlling the pandemic. In this review, the
author discusses important viral targets such as the papain-like protease, RNA-dependent RNA polymerase,
3-chymotrypsin-like protease, and spike protein. The information about chemical compounds and targets
provided in this review will aid further in vitro and in vivo studies to discover drugs to treat COVID-19.
Downloads
Published
2021-03-24
Issue
Section
Articles
License
- The journal allows readers to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose.
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to retain publishing rights without restrictions
How to Cite
Discovery of Therapeutic Targets and Potential Drugs to Fight Severe Acute Respiratory Syndrome Coronavirus 2 (SARSCoV-2): A Review. (2021). Indian Journal of Forensic Medicine & Toxicology, 15(2), 2396-2401. https://doi.org/10.37506/ijfmt.v15i2.14731